Drug-coated balloons for treatment of coronary artery disease: Updated recommendations from a consensus group

Clinical Research in Cardiology

Volumn 102, Issue 11, 2013, Pages 785-797

  Kleber, Franz X ^a   Rittger, Harald ^b   Bonaventura, Klaus ^c   Zeymer, Uwe ^d   Wöhrle, Jochen ^e   Jeger, Raban ^f   Levenson, Benny ^g   Möbius Winkler, Sven ^h   Bruch, Leonhard ⁱ   Fischer, Dieter ^j   Hengstenberg, Christian ^k   Pörner, Tudor ^l   Mathey, Detlef ^m   Scheller, Bruno ⁿ  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Ernst von Bergmann Klinikum   (Germany)

^d KLINIKUM LUDWIGSHAFEN   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g Kardiologische Gemeinschaftspraxis   (Germany)

^h Experimental and Clinical Research Center   (Germany)

ⁱ Klinik fur Innere Medizin   (Germany)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l JENA UNIVERSITY HOSPITAL   (Germany)

^m UNIVERSITY HEART CENTER HAMBURG   (Germany)

ⁿ SAARLAND UNIVERSITY   (Germany)

more..

Author keywords

DCB only; Drug coated balloon; Dual antiplatelet therapy; In stent restenosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CATECHOLAMINE; CHROMIUM; CLOPIDOGREL; COBALT; CYPHER; DANUBIO; DIOR I; DIOR II; ELUTAX; IN PACT FALCON; IOPROMIDE; MOXY; PACLITAXEL; PANTERA LUX; PRASUGREL; PROTEGE NC; RAPAMYCIN; TAXUS LIBERTE; TICAGRELOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANGIOPLASTY; ATHEROSCLEROSIS; BALLOON CATHETER; BARE METAL STENT; BRACHYTHERAPY; CAROTID ARTERY BIFURCATION; CLINICAL EFFECTIVENESS; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DRUG COATED BALLOON CATHETER; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTRACORONARY VASCULAR BRACHYTHERAPY; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON; CONSENSUS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; HUMANS; PERIPHERAL ARTERIAL DISEASE; PLAQUE, ATHEROSCLEROTIC;

EID: 84886445617     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0609-7     Document Type: Review

References (71)

1. Gruntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263
2. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701-706
3. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773-1780
4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193-202
5. Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R (2009) One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging 2:625-628
6. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110:810-814
7. Kleber FX, Scheller B, Serruys PW (2011) New technologies in percutaneous coronary interventions: Drug-coated balloons. EuroIntervention 7(Suppl K):K7
8. Scheller B (2011) Opportunities and limitations of drug-coated balloons in interventional therapies. Herz 36:232-240
9. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113-2124
10. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U (2008) Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 97:773-781
11. Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Speck U, Bohm M, Cremers B (2012) Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv 5:323-330
12. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119:2986-2994
13. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99:165-174
14. Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX (2011) Treatment of bifurcation lesions with a drug-eluting balloon: the pepcad v (paclitaxel eluting ptca balloon in coronary artery disease) trial. EuroIntervention 7(Suppl K):K61-K65
15. Wohrle J, Birkemeyer R, Markovic S, Nguyen TV, Sinha A, Miljak T, Spiess J, Rottbauer W, Rittger H (2011) Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 97:1338-1342
16. Rosli R, Zambahari R et al (2011) Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7:K83-K91
17. Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4:149-154
18. Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, Brugger A, Thiele H, Birkemeyer R, Kurowski V, Breithardt OA, Schmidt M, Zimmermann S, Lonke S, von Cranach M, Nguyen TV, Daniel WG, Wohrle J (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The pepcad-des study. J Am Coll Cardiol 59:1377-1382
19. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwalder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358:689-699
20. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J (2008) Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation 118:1358-1365
21. Vajda Z, Guthe T, Perez MA, Heuschmid A, Schmid E, Bazner H, Henkes H (2011) Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol 32:1942-1947
22. Wohrle J, Zadura M, Mobius-Winkler S, Leschke M, Opitz C, Ahmed W, Barragan P, Simon JP, Cassel G, Scheller B (2012) Sequent please world wide registry: clinical results of sequent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol 60:1733-1738
23. Kleber FX, Mathey DG, Rittger H, Scheller B (2011) How to use the drug-eluting balloon: recommendations by the german consensus group. EuroIntervention 7(Suppl K):K125-K128
24. Hermans WR, Rensing BJ, Foley DP, Deckers JW, Rutsch W, Emanuelsson H, Danchin N, Wijns W, Chappuis F, Serruys PW (1992) Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The mercator study group (multicenter european research trial with cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis). J Am Coll Cardiol 20:767-780
25. Ellis SG, Roubin GS, King SB, Douglas JS, Weintraub WS, Thomas RG, Cox WR (1988) Angiographic and clinical predictors of acute closure after native vessle coronary angioplasty. Circulation 77:372-379
26. Leimgruber PP, Roubin GS, Anderson HV, Bredlau CE, Whitworth HB, Douglas JS Jr, King SB 3rd, Greuntzig AR (1985) Influence of intimal dissection on restenosis after successful coronary angioplasty. Circulation 72:530-535
27. Cappelletti A, Margonato A, Rosano G, Mailhac A, Veglia F, Colombo A, Chierchia SL (1999) Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty. J Am Coll Cardiol 34:1484-1488
28. Huber MS, Mooney JF, Madison J, Mooney MR (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68:467-471
29. Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, Kappenberger L (1988) Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 78:1121-1127
30. Fishman DL, Leoan MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailer S, Ellis S, Rake R, Goldberg S (1994) Investigators ftSRS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501
31. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ (1994) Heuvel Pvd, Delcan J, Morel M-A, Group ftBS. A comparison of ballon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495
32. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB (2004) Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 147:815-822
33. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM (1995) Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91:1676-1688
34. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE (1998) A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators. N Engl J Med 339:1665-1671
35. Latib A, Colombo A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Menozzi A (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the bello (balloon elution and late loss optimization) study. J Am Coll Cardiol 60:2473-2480
36. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A (2005) Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293:165-171
37. Waksman R, Bhargava B, White RL, Chan RC, Gierlach LM, Mehran R, Lansky A, Kent KM, Mintz GS, Satler LF, Pichard AD, Leon MB (1999) Intracoronary radiation for patients with refractory in-stent restenosis: an analysis from the wrist-crossover trial. Washington radiation for in-stent restenosis trial. Cardiovasc Radiat Med 1:317-322
38. Waksman R (2012) Too early to call. Cardiovasc Revasc Med 13:157-158
39. Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schomig A, Kastrati A (2010) Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the isar-desire 2 (intracoronary stenting and angiographic results: Drug eluting stents for in-stent restenosis 2) study. J Am Coll Cardiol 55:2710-2716
40. Alfonso F, Perez-Vizcayno MJ, Dutary J, Zueco J, Cequier A, Garcia-Touchard A, Marti V, Lozano I, Angel J, Hernandez JM, Lopez-Minguez JR, Melgares R, Moreno R, Seidelberger B, Fernandez C, Hernandez R, Investigators R-IS (2012) Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis: results from a prospective multicenter study (ribs iii [restenosis intra-stent: Balloon angioplasty versus drug-eluting stent]). JACC Cardiovasc Interv 5:728-737
41. Alli OO, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA, Holmes DR Jr, Investigators S (2012) Five-year follow-up of the sirolimus-eluting stents vs vascular brachytherapy for bare metal in-stent restenosis (sisr) trial. Am Heart J 163:438-445
42. Raber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, Juni P, Serruys PW, Windecker S (2012) Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation 125:1110-1121
43. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y, Sabate M, Starc R, Thielmann M, Wheatley DJ, Windecker S, Zembala M (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (esc) and the european association for cardio-thoracic surgery (eacts). Eur Heart J 31:2501-2555
44. Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, Schulz S, Fusaro M, Ott I, Ibrahim T, Hausleiter J, Valina C, Pache J, Laugwitz KL, Massberg S, Kastrati A (2013) Investigators I-D. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (isar-desire 3): a randomised, open-label trial. Lancet 381:461-467
45. Bonaventura K, Leber AW, Sohns C, Roser M, Boldt LH, Kleber FX, Haverkamp W, Dorenkamp M (2012) Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease. Clin Res Cardiol 101:573-584
46. Dorenkamp M, Boldt J, Leber A, Sohns C, Roser M, Boldt L, Haverkamp W, Bonaventura K (2013) Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis. Clin. Cardiol 36:407-413
47. Cremers B, Clever Y, Schaffner S, Speck U, Bohm M, Scheller B (2010) Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol 58:583-588
48. Hehrlein C, Dietz U, Kubica J, Jorgensen E, Hoffmann E, Naber C, Lesiak M, Schneider H, Wiemer M, Tolg R, Richardt G (2012) Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis first-in-man (pepper) trial. Cardiovasc Revasc Med 13:260-264
49. Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J (2012) Comparison of two drug-eluting balloons: a report from the scaar registry. EuroIntervention 8:444-449
50. Moreno R, Fernandez C, Alfonso F, Hernandez R, Perez-Vizcayno MJ, Escaned J, Sabate M, Banuelos C, Angiolillo DJ, Azcona L, Macaya C (2004) Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol 43:1964-1972
51. Agostoni P, Biondi-Zoccai GG, Gasparini GL, Anselmi M, Morando G, Turri M, Abbate A, McFadden EP, Vassanelli C, Zardini P, Colombo A, Serruys PW (2005) Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J 26:881-889
52. Brunner-La Rocca HP, Kaiser C, Pfisterer M (2007) Targeted stent use in clinical practice based on evidence from the basel stent cost effectiveness trial (basket). Eur Heart J 28:719-725
53. Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, Limbruno U (2010) Paclitaxel-coated balloon versus drug-eluting stent during pci of small coronary vessels, a prospective randomised clinical trial. The piccoleto study. Heart 96:1291-1296
54. Behan MW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemela M, Cooter N, Chew DP, Steigen TK, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L, Hildick-Smith D (2011) Simple or complex stenting for bifurcation coronary lesions: A patient-level pooled-analysis of the nordic bifurcation study and the british bifurcation coronary study. Circ Cardiovasc Interv 4:57-64
55. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L (2006) Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 114:1955-1961
56. Erglis A, Kumsars I, Niemela M, Kervinen K, Maeng M, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galloe A, Narbute I, Sondore D, Makikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Syvanne M, Helqvist S, Kjell N, Wiseth R, Aaroe J, Puhakka M, Thuesen L (2009) Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study. Circ Cardiovasc Interv 2:27-34
57. Stella PR, Belkacemi A, Dubois C, Nathoe H, Dens J, Naber C, Adriaenssens T, van Belle E, Doevendans P, Agostoni P (2012) A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv 80:1138-1146
58. Ali RM, Degenhardt R, Zambahari R, Tresukosol D, Ahmad WA, Kamar HH, Kui-Hian S, Ong TK, bin Ismail O, bin Elis S, Udychalerm W, Ackermann H, Boxberger M, Unverdorben M (2011) Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7(Suppl K):K83-K92
59. Scheller B, Clever Y, Bohm M, Cremers B (2012) Drug coated balloons in acute coronary syndromes-opportunities and limitations. Curr Vasc Pharmacol 10:472-475
60. Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR (2012) First results of the deb-ami (drug eluting balloon in acute st-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol 59:2327-2337
61. Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, Eschenbach G, Hartmann H, Lange C, Schnorr B, Stiepani H, Zoccai GB, Hanninen EL (2012) Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized pacifier trial. Circ Cardiovasc Interv 5:831-840
62. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D (2011) First experience with drug-eluting balloons in infrapopliteal arteries restenosis rate and clinical outcome. J Am Coll Cardiol 58:1105-1109
63. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA (2011) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58:1578-1588
64. Wohrle J, Werner GS (2012) Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries. Catheter Cardiovasc Interv 81:793-799
65. Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W (2011) Optical coherence tomography (oct) in pci for in-stent restenosis (isr): rationale and design of the seduce (safety and efficacy of a drug eluting balloon in coronary artery restenosis) study. EuroIntervention 7(Suppl K):K100-K105
66. Poerner TC, Otto S, Gassdorf J, Janiak F, Danzer C, Ferrari M, Figulla HR (2011) A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (octopus trial): rationale, design and methods. EuroIntervention 7(Suppl K):K93-K99
67. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA (2008) Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the debiut (drug-eluting balloon in bifurcation utrecht) registry. Catheter Cardiovasc Interv 71:629-635
68. Stella PR, Belkacemi A, Waksman R, Stahnke S, Torguson R, von Strandmann RP, Agostoni P, Sangiorgi G, Silber S, Valentine I (2011) The valentine's trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation dior paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention 7:705-710
69. Vaquerizo B, Serra A, Miranda-Guardiola F, Martinez V, Antoni Gomez-Hospital J, Iniguez A, Fernandez E, Ramon Rumoroso J, Bosa F, Otaegui I (2011) One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry. J Interv Cardiol 24:518-528
70. Mieres J, Fernandez-Pereira C, Risau G, Solorzano L, Pauletto R, Rodriguez-Granillo AM, Rubilar B, Stella P, Rodriguez AE (2012) One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the diabetic Argentina registry (dear). Cardiovasc Revasc Med 13:265-271
71. Gutierrez-Chico JL, van Geuns RJ, Koch KT, Koolen JJ, Duckers H, Regar E, Serruys PW (2011) Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs Stent first. EuroIntervention 7:711-722